CLOZAPINE

Drug Mylan Inc.
Total Payments
$25,298
Transactions
129
Doctors
9
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $25,232 127 7
2017 $66.66 2 2

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $22,953 6 90.7%
Travel and Lodging $1,666 40 6.6%
Food and Beverage $612.54 81 2.4%
Education $66.66 2 0.3%

Top Doctors Receiving Payments for CLOZAPINE

Doctor Specialty Location Total Records
, MD Psychiatry Lebanon, NH $9,127 37
John Kane Psychiatry Glen Oaks, NY $9,007 41
, M.D., PH.D Internal Medicine Boston, MA $4,302 26
, M.D Anesthesiology Setauket, NY $1,080 12
, MD Psychiatry Los Angeles, CA $901.53 8
, M.D Public Health & General Preventive Medicine Reston, VA $801.68 2
, DO Psychiatry Omaha, NE $33.33 1
, MD Psychiatry Garfield Heights, OH $33.33 1
, MD Psychiatry Dallas, TX $13.25 1

About CLOZAPINE

CLOZAPINE is a drug associated with $25,298 in payments to 9 healthcare providers, recorded across 129 transactions in the CMS Open Payments database. The primary manufacturer is Mylan Inc..

Payment data is available from 2017 to 2024. In 2024, $25,232 was paid across 127 transactions to 7 doctors.

The most common payment nature for CLOZAPINE is "Consulting Fee" ($22,953, 90.7% of total).